Hamburg, Germany - 16 October 2013: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that its R&D Day 2013 will take place on 22 October 2013 in New York City, USA. At the meeting, Evotec will provide an overview of the Company's systematic, unbiased and comprehensive drug discovery infrastructures and its core disease areas.
Furthermore, Prof Dr Doug Melton will hold a presentation on regenerative medicine regarding beta cell function.
Evotec R&D Day 2013
Date: Tuesday, 22 October 2013, 11:30 am EST (04:30 pm GMT, 05:30 pm CET)
Venue: New York, NY, USA
Dr Werner Lanthaler, Chief Executive Officer of Evotec
Dr Cord Dohrmann, Chief Scientific Officer of Evotec
Prof Dr Doug Melton, Xander University Professor in the Department of Stem Cell and Regenerative Biology at Harvard University, Harvard Stem Cell Institute Scientific Co-Director and Howard Hughes Medical Institute Investigator
There will be a live webcast of this event: http://evotec.equisolvewebcast.com/rd-day. The PDF version of the presentation will be provided at www.evotec.com shortly before the event.